CL2016001447A1 - Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal. - Google Patents

Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.

Info

Publication number
CL2016001447A1
CL2016001447A1 CL2016001447A CL2016001447A CL2016001447A1 CL 2016001447 A1 CL2016001447 A1 CL 2016001447A1 CL 2016001447 A CL2016001447 A CL 2016001447A CL 2016001447 A CL2016001447 A CL 2016001447A CL 2016001447 A1 CL2016001447 A1 CL 2016001447A1
Authority
CL
Chile
Prior art keywords
site
mediastinum
sinuses
chlorhexidine
colon
Prior art date
Application number
CL2016001447A
Other languages
English (en)
Inventor
Carolyn L Twomey
Gareth Clarke
Samuel J Zaidspiner
Original Assignee
Innovation Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Innovation Tech Inc filed Critical Innovation Tech Inc
Publication of CL2016001447A1 publication Critical patent/CL2016001447A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00051—Accessories for dressings
    • A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
    • A61L2300/206—Biguanides, e.g. chlorohexidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Materials Engineering (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento para reducir la infección en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal. Para ello la solución puede ser aplicada directamente o en diversos dispositivos médicos.
CL2016001447A 2013-12-12 2016-06-10 Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal. CL2016001447A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361915281P 2013-12-12 2013-12-12

Publications (1)

Publication Number Publication Date
CL2016001447A1 true CL2016001447A1 (es) 2017-04-07

Family

ID=53367098

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016001447A CL2016001447A1 (es) 2013-12-12 2016-06-10 Uso de una solución acuosa de clorhexidina (<1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.

Country Status (15)

Country Link
US (9) US9642820B2 (es)
EP (1) EP3079681B1 (es)
JP (2) JP2017503852A (es)
KR (1) KR20160096678A (es)
CN (1) CN105979940A (es)
AU (2) AU2014361828A1 (es)
BR (1) BR112016013199A2 (es)
CA (1) CA2933065C (es)
CL (1) CL2016001447A1 (es)
IL (1) IL246087A0 (es)
MX (1) MX2016007679A (es)
PH (1) PH12016501099A1 (es)
RU (1) RU2682642C1 (es)
SG (2) SG10201811454WA (es)
WO (1) WO2015089421A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0808376D0 (en) 2008-05-08 2008-06-18 Bristol Myers Squibb Co Wound dressing
GB0817796D0 (en) 2008-09-29 2008-11-05 Convatec Inc wound dressing
GB201020236D0 (en) 2010-11-30 2011-01-12 Convatec Technologies Inc A composition for detecting biofilms on viable tissues
EP2648793B1 (en) 2010-12-08 2020-03-11 ConvaTec Technologies Inc. Integrated system for assessing wound exudates
CN103347562B (zh) 2010-12-08 2016-08-10 康沃特克科技公司 伤口分泌液系统附件
GB201115182D0 (en) 2011-09-02 2011-10-19 Trio Healthcare Ltd Skin contact material
GB2497406A (en) 2011-11-29 2013-06-12 Webtec Converting Llc Dressing with a perforated binder layer
GB201120693D0 (en) 2011-12-01 2012-01-11 Convatec Technologies Inc Wound dressing for use in vacuum therapy
BR112015014816A2 (pt) 2012-12-20 2017-07-11 Convatec Technologies Inc processamento de fibras celulósicas modificadas quimicamente
CA2933065C (en) * 2013-12-12 2021-08-24 Innovation Technologies, Inc. Materials and methods for controlling infections
US10016375B2 (en) 2013-12-12 2018-07-10 Paul J. Rucinski Materials and methods for controlling infections
US9848604B2 (en) 2014-07-11 2017-12-26 Medtronic Xomed, Inc. Antimicrobial wash
US20160038442A1 (en) * 2014-08-08 2016-02-11 Innovation Technologies, Inc. Materials and methods for controlling infections with negative pressure wound therapy
PL3435941T3 (pl) 2016-03-30 2022-05-09 Convatec Technologies Inc. Wykrywanie infekcji drobnoustrojowych w ranach
JP2019513238A (ja) 2016-03-30 2019-05-23 クオリザイム・ダイアグノスティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・コムパニー・コマンディットゲゼルシャフトＱｕａｌｉｚｙｍｅ Ｄｉａｇｎｏｓｔｉｃｓ Ｇｍｂｈ Ａｎｄ Ｃｏ． Ｋｇ 創傷における微生物感染の検出
BR112018072647A2 (pt) * 2016-05-06 2019-02-19 SaCSh Corp. composições oftálmicas
BR112019000284A2 (pt) 2016-07-08 2019-04-16 Convatec Technologies Inc. aparelho de coleta de fluido
JP7071957B2 (ja) 2016-07-08 2022-05-19 コンバテック・テクノロジーズ・インコーポレイテッド 可撓性陰圧システム
MX2019000232A (es) 2016-07-08 2019-11-12 Convatec Technologies Inc Deteccion de flujo de fluidos.
AU2017347819A1 (en) * 2016-10-26 2019-05-23 Innovation Technologies, Inc. Materials and methods for the control of biofilm
WO2019060697A1 (en) 2017-09-22 2019-03-28 Becton, Dickinson And Company 4% TRISODIC CITRATE SOLUTION FOR USE AS A CATHETER LOCK SOLUTION
US20190117569A1 (en) * 2017-10-24 2019-04-25 Saint Anthony Biomedical, LLC Compositions and methods for reducing infection in wounds and surgical sites
WO2020005785A1 (en) * 2018-06-26 2020-01-02 Innovation Technologies, Inc. Pyrogen binding composition and use of same in treatment and prevention of sepsis
SG11202112292QA (en) 2019-06-03 2021-12-30 Convatec Ltd Methods and devices to disrupt and contain pathogens
US11771819B2 (en) 2019-12-27 2023-10-03 Convatec Limited Low profile filter devices suitable for use in negative pressure wound therapy systems
US11331221B2 (en) 2019-12-27 2022-05-17 Convatec Limited Negative pressure wound dressing
CN112294789B (zh) * 2020-10-15 2022-06-07 郑涛 用于防治呼吸道感染的复方制剂及其应用
JP2023550402A (ja) * 2020-11-18 2023-12-01 アンスティテュ・クリー ビグアニジンの二量体及びその治療的使用
US11722993B2 (en) * 2021-03-23 2023-08-08 Qualcomm Incorporated Techniques for configuring resources in a sidelink resource pool
US11951087B2 (en) 2021-07-27 2024-04-09 Lanny Leo Johnson Eye wash compositions and methods
WO2023052829A1 (en) * 2021-10-02 2023-04-06 Desert King Chile S.A A 3-o-monodesmosidic saponins extract, stable at physiological ph, method for preparing it from a quillaja plant extract cultured with a microbial consortium, uses and such microbial consortium

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2090354A (en) * 1936-05-14 1937-08-17 Abraham E Massman Combined medicine dropper and swab
US4299221A (en) * 1979-09-28 1981-11-10 Stryker Corporation Irrigation and suction handpiece
US4704102A (en) * 1982-09-30 1987-11-03 Geneco Inc. Method of eliminating intra abdominal infections
US5002769A (en) * 1987-03-13 1991-03-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions for the sustained-release of chlorhexidine
IE883722L (en) * 1988-12-14 1990-06-14 Galway Dental Technology Ltd Fluid dispenser for the treatment of a dental disorder
US4925668A (en) * 1989-01-18 1990-05-15 Becton, Dickinson And Company Anti-infective and lubricious medical articles and method for their preparation
US5002528A (en) * 1989-12-15 1991-03-26 Aubrey Palestrant Percutaneous irrigation and drainage system
US5333603A (en) * 1992-02-25 1994-08-02 Daniel Schuman Endoscope with palm rest
US6558686B1 (en) * 1995-11-08 2003-05-06 Baylor College Of Medicine Method of coating medical devices with a combination of antiseptics and antiseptic coating therefor
JPH09301858A (ja) * 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd グルコン酸クロルヘキシジン安定化水性薬剤
US5725311A (en) 1996-07-19 1998-03-10 Sage Products, Inc. Resealable package with label peeling inhibiting means
JP3054758B2 (ja) * 1997-03-27 2000-06-19 小林製薬株式会社 外傷用組成物
US5906278A (en) 1997-10-06 1999-05-25 Sage Products, Inc. Patient bathing system
US5956794A (en) 1997-10-31 1999-09-28 Sage Products, Inc. Patient bathing system and washcloth for body cleansing
RU2166314C2 (ru) * 1999-07-06 2001-05-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Лечебно-профилактическое средство "гексикон", обладающее антибактериальным и антисептическим действием
US7066932B1 (en) * 2001-05-26 2006-06-27 Map Technologies Llc Biologically enhanced irrigants
US6964653B2 (en) * 2002-02-06 2005-11-15 Felipe Negron Multi-use hygienic cleansing device
US7066916B2 (en) 2003-05-12 2006-06-27 Sage Products, Inc. Disinfectant delivery system, and method of providing alcohol-free disinfection
RU2240821C1 (ru) * 2003-06-02 2004-11-27 Научно-исследовательский институт вакцин и сывороток им. И.И.Мечникова РАМН Способ лечения урогенитальных инфекций
IL156945A0 (en) * 2003-07-15 2004-02-08 Itzhak Tavori Device and a method for orthopedic delivery of bone reconstruction medium
JP2007505724A (ja) * 2003-09-22 2007-03-15 イノベーション テクノロジーズ インコーポレーティッド 創傷洗浄の装置および方法
US20050191247A1 (en) 2004-03-01 2005-09-01 David Drake Chlorhexidine compositions
CA2612729C (en) * 2005-07-01 2018-02-27 Kane Biotech Inc. Antimicrobial compositions for inhibiting growth and proliferation of a microbial biofilm on medical devices
US20080139450A1 (en) * 2005-07-01 2008-06-12 Srinivasa Madhyastha Antimicrobial Compositions and Uses Thereof
WO2008060380A2 (en) * 2006-10-18 2008-05-22 Arrow International, Inc. Anti-infective alcohol catheter solution with chlorhexidine treated catheter
US20110097372A1 (en) 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
GB0716605D0 (en) * 2007-08-24 2007-10-03 Univ Aston Skin antiseptics
US8696820B2 (en) * 2008-03-31 2014-04-15 Bard Access Systems, Inc. Method of removing a biofilm from a surface
WO2009124386A1 (en) 2008-04-07 2009-10-15 Interface Biologics Inc. Combination therapy for the treatment of bacterial infections
CA2732307C (en) * 2008-08-01 2017-01-24 Ondine International Ltd. Composition and method for treatment of mrsa
US8622996B2 (en) * 2008-10-27 2014-01-07 Pursuit Vascular, Inc. Method for applying antimicrobial to proximal end of catheter
RU2455037C2 (ru) * 2009-05-14 2012-07-10 Государственное образовательное учреждение высшего профессионального образования "Челябинская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Способ локальной иммунокоррекции инфекционно-воспалительных заболеваний урогенитального тракта женщин, вызванных микроорганизмами, передаваемыми половым путём
JP5639345B2 (ja) * 2009-05-27 2014-12-10 花王株式会社 バイオフィルム除去剤組成物
RU2404430C1 (ru) * 2009-07-27 2010-11-20 Ирина Дмитриевна Евтушенко Способ диагностики атрофии влагалища у женщин репродуктивного возраста в состоянии постовариоэктомии
CA2778081A1 (en) 2009-10-26 2011-05-12 Innovation Technologies, Inc. Devices, methods, and composition for controlling infections
US8343525B2 (en) 2009-12-22 2013-01-01 Becton, Dickinson And Company Chlorhexidine acetate antiseptic cleaning agent
DK2600869T3 (da) 2010-08-05 2020-11-16 Helperby Therapeutics Ltd Kombination af en pyrroloquinolinforbindelse og et beta-lactam-antimikrobielt middel, mupirocin eller chlorhexidin
US8529546B2 (en) * 2010-10-21 2013-09-10 John J. Martinez Sinusal guide cannula and kit for irrigation, suction and washing
US20120150131A1 (en) * 2010-12-09 2012-06-14 Teleflex Medical Incorporated Polymer for Controlling Delivery of Bioactive Agents and Method of Use
EP2750625A4 (en) * 2011-08-31 2015-08-19 Univ Columbia REDUCING BIOFILMS ON MEDICAL DEVICES
US9327095B2 (en) * 2013-03-11 2016-05-03 Becton, Dickinson And Company Blood control catheter with antimicrobial needle lube
CN103211805A (zh) * 2013-04-18 2013-07-24 江苏健裕健康医疗器械有限公司 洗必泰葡萄糖酸盐复合消毒液
US9345414B1 (en) 2013-09-25 2016-05-24 Bardy Diagnostics, Inc. Method for providing dynamic gain over electrocardiographic data with the aid of a digital computer
CA2933065C (en) * 2013-12-12 2021-08-24 Innovation Technologies, Inc. Materials and methods for controlling infections

Also Published As

Publication number Publication date
BR112016013199A2 (pt) 2020-06-30
US20180221311A1 (en) 2018-08-09
MX2016007679A (es) 2017-02-28
IL246087A0 (en) 2016-07-31
KR20160096678A (ko) 2016-08-16
CA2933065A1 (en) 2015-06-18
US20190307709A1 (en) 2019-10-10
JP2019189613A (ja) 2019-10-31
US20150164829A1 (en) 2015-06-18
US20200289435A1 (en) 2020-09-17
US20160279080A1 (en) 2016-09-29
EP3079681A4 (en) 2017-11-22
US9931310B2 (en) 2018-04-03
US10172813B2 (en) 2019-01-08
AU2018271354A1 (en) 2019-01-17
US11559503B2 (en) 2023-01-24
EP3079681A1 (en) 2016-10-19
US20180055794A1 (en) 2018-03-01
AU2014361828A1 (en) 2016-06-30
EP3079681B1 (en) 2022-06-01
US20160271079A1 (en) 2016-09-22
US10507191B2 (en) 2019-12-17
WO2015089421A1 (en) 2015-06-18
CN105979940A (zh) 2016-09-28
US20180055793A1 (en) 2018-03-01
US20210259996A1 (en) 2021-08-26
AU2018271354B2 (en) 2020-05-21
US9642820B2 (en) 2017-05-09
SG10201811454WA (en) 2019-01-30
PH12016501099A1 (en) 2016-07-11
US11033517B2 (en) 2021-06-15
RU2682642C1 (ru) 2019-03-20
CA2933065C (en) 2021-08-24
US9668989B2 (en) 2017-06-06
SG11201604596RA (en) 2016-07-28
US10226437B2 (en) 2019-03-12
US10682318B2 (en) 2020-06-16
JP2017503852A (ja) 2017-02-02

Similar Documents

Publication Publication Date Title
CL2016001447A1 (es) Uso de una solución acuosa de clorhexidina (&lt;1%) para la preparación de un medicamento o dispositivos medicos de aplicación, para reducir la infección en un sujeto, en la sangre, tracto urogenital, tracto respiratorio, sitio intraperitoneal, colon, senos nasales, sitio intra-articular, en el mediastino o un sitio cerebroespinal.
BR112015007659A2 (pt) mecanismos químicos e métodos para o uso dos mesmos, especialmente na injeção de fluidos altamente viscosos
BR112015020118A2 (pt) derivados de 2-aminopirimidina para o tratamento de infecções virais
BR112015011036A2 (pt) derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais
EA201591004A1 (ru) Производные бороновой кислоты и их терапевтическое применение
BR112015007366A2 (pt) derivados de acilaminopirimidina para o tratamento de infecções virais e outras doenças
BR112015027704A2 (pt) Composto, uso do mesmo e composição farmacêutica antibacteriana
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
CL2015003690A1 (es) Uso de pridopidina o una sal de la misma para preparar un medicamento útil en el tratamiento de la enfermedad de huntington.
UA116648C2 (uk) Фумарати як проліки та їх застосування при лікуванні різних захворювань
PE20160045A1 (es) Polipeptidos f de prefusion del virus sincicial respiratorio (rsv) solubles y estabilizados
CY1119151T1 (el) Ν-(4-(αζαϊνδαζολ-6-υλ)-φαινυλ)-σουλφοναμιδiα και η χρηση τους ως φαρμακα
CR20150480A (es) Composición farmacéutica de clorhidrato de s-cetamina
EA201591624A1 (ru) Новые производные пиразола
AR098168A1 (es) Formulación estable de insulina glulisina
EA201591679A1 (ru) Способ нетоксического лечения абстиненции, вызванной лекарственным средством
BR112015027477A8 (pt) bolus, seus usos, e kit
CL2015002346A1 (es) Estra-1,3,5(10),16-tetraeno-3-carboxamidas para la inhibicion de la 17b-hidroxiesteroide deshidrogenasa (akr1 c3)
PE20160012A1 (es) Tratamiento de enfermedades miopaticas y neurogenerativas por agregacion de proteina mediante administracion parenteral
CR20150019A (es) Derivados de carbamato/urea
ECSP16096831A (es) Derivados de naftiridinadiona
CL2014003012A1 (es) Formulación en capsulas que comprende al menos un compuesto de formula (i), solubilizado; metodo de administracion de la formulacion; uso para tratar una infeccion por el virus de la hepatitis c.
BR112015028876A2 (pt) derivados de perhidroquinoxalina
GT201300125A (es) 1h-pirazol-5-olato sódico sustituido
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel